


Nervosave Therapeutics
Biotechnology Research • Montpellier, Occitanie, France • 1-10 Employees
Company overview
| Headquarters | Montpellier, Occitanie, France |
| Website | |
| Founded | 2021 |
| Employees | 1-10 |
| Socials |
Key Contact at Nervosave Therapeutics
Nicolas Tricaud
Chief Executive Officer
Nervosave Therapeutics Email Formats
Nervosave Therapeutics uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@nervosavetx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@nervosavetx.com | 100% |
About Nervosave Therapeutics
Nervosave Therapeutics discovers and develops therapies that slow, stop and reverse a broad range of demyelinating peripheral nerve diseases. Our first aim is to develop best in class Gene Therapy for CMT1A patients and beyond for all demyelinating CMT diseases. We develop robust discovery programs targeting both CMT diseases and acquired demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome.
Nervosave Therapeutics revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
Nervosave Therapeutics has 2 employees across 1 departments.
Departments
Number of employees
Funding Data
Nervosave Therapeutics has never raised funding before.
Nervosave Therapeutics Tech Stack
Discover the technologies and tools that power Nervosave Therapeutics's digital infrastructure, from frameworks to analytics platforms.
Security
Databases
JavaScript libraries
Page builders
JavaScript libraries
JavaScript libraries
Programming languages
Blogs
Analytics
SEO
WordPress themes
Tag managers
Frequently asked questions
4.8
40,000 users



